AWS for Industries
Tag: biopharma
Finding enduring solutions to the evolving COVID-19 crisis
Blog guest authored by Bo Barnhart, Vice President of Translational Research at AbCellera In February 2020, AbCellera mobilized its pandemic response platform to find treatments for COVID-19. Supported by Amazon Web Services (AWS), AbCellera discovered two antibody treatments, bamlanivimab and bebtelovimab, for COVID-19 in a year, breaking records to keep pace with an evolving pandemic. […]
Bridging Conventional GxP Solutions with the AWS Cloud: An Approach to Adopting Cloud Services
The cloud has brought agility and cost savings compared to running workloads in a data center, forcing customers to consider how regulatory concerns are shared between themselves and the cloud provider. Customers with existing GxP (an abbreviation for “good practice” guidelines and regulations for various industries like pharmaceutical, agricultural, or manufacturing) solutions are challenged when […]
Introducing AWS for Health – Accelerating innovation from benchtop to bedside
Healthcare and life science organizations are moving towards digital transformation to decrease the cost of care, improve collaboration, make data-driven clinical and operational decisions, and enable faster development of new therapeutics and treatment paths. Identifying the right cloud technology to reach these goals can be challenging, and many organizations lack the internal resourcing and expertise […]
Executive Conversations: Modernizing the approach to healthcare data with Andrew Goldberg, Co-founder and COO of HealthVerity
Andrew Goldberg, Co-founder and COO of HealthVerity, joins Jared Saul, Global Head of Healthcare and Life Sciences Startups at AWS, for a discussion on industry trends shaping the way payors and pharmaceutical organizations exchange and manage data, the role of real-time data in COVD-19 vaccine development, and a vision for a flexible data strategy. HealthVerity, […]
Executive Conversations: Advancing modern clinical trials with Dave Kelleher, CEO and founder of 4G Clinical
Dave Kelleher, CEO and founder of 4G Clinical, joins Joe Shonkwiler, MD, Principal Business Development Manager, Startups and Investors for Healthcare and Life Sciences at AWS, for a discussion on the impact of COVID-19 on clinical trial designs, direct-to-patient use cases, and what’s next for the pharmaceutical industry. 4G Clinical is a leader in randomization […]
[In the News] The Intelligent Era: Design, Detect, Discover
This article originally appeared on BBC StoryWorks. How machine learning is changing the pharmaceutical industry and reshaping the way drugs are produced in the 21st century The scale of the pharmaceutical industry is staggering. There are millions of patients to take care of, billions of data points generated by every clinical trial—and that’s before you […]